Elaine Mcwhirter

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Meaningful efficacy measures and trial endpoints in patients with advanced melanoma being considered for adjuvant systemic therapy: a prospective patient survey study.

Meaningful efficacy measures and trial endpoints in patients with advanced melanoma being considered for adjuvant systemic therapy: a prospective patient survey study.

Journal: Melanoma research

Published: August 15, 2025

Efficacy and safety of adjuvant systemic therapies in trial non-eligible resected stages III and IV melanoma patients.

Efficacy and safety of adjuvant systemic therapies in trial non-eligible resected stages III and IV melanoma patients.

Journal: Melanoma management

Published: February 17, 2025

Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic review.

Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic review.

Journal: Surgical oncology

Published: January 17, 2024

Pembrolizumab-induced immune-related sclerosing cholangitis.

Pembrolizumab-induced immune-related sclerosing cholangitis.

Journal: BMJ case reports

Published: November 01, 2023

Multisystem Immune-Related Adverse Events from Dual-Agent Immunotherapy Use.

Multisystem Immune-Related Adverse Events from Dual-Agent Immunotherapy Use.

Journal: Current oncology (Toronto, Ont.)

Published: October 17, 2023

An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Surveillance Strategies in Patients with Stage I, II, III or Resectable IV Melanoma Who Were Treated with Curative Intent.

An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Surveillance Strategies in Patients with Stage I, II, III or Resectable IV Melanoma Who Were Treated with Curative Intent.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: October 06, 2023

Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review.

Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review.

Journal: Journal for immunotherapy of cancer

Published: July 11, 2023

Immune-Checkpoint Induced Skin Toxicity Masked as Squamous Cell Carcinoma: Case Report on Mimickers of Dermatological Toxicity with PD-1 Inhibition.

Immune-Checkpoint Induced Skin Toxicity Masked as Squamous Cell Carcinoma: Case Report on Mimickers of Dermatological Toxicity with PD-1 Inhibition.

Journal: Current oncology (Toronto, Ont.)

Published: April 03, 2023

A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma.

A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma.

Journal: Journal of gastrointestinal oncology

Published: January 25, 2022

KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation.

KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 07, 2021

Canadian cohort expanded-access program of nivolumab plus ipilimumab in advanced melanoma.

Canadian cohort expanded-access program of nivolumab plus ipilimumab in advanced melanoma.

Journal: Current oncology (Toronto, Ont.)

Published: September 09, 2020

Systemic adjuvant therapy for adult patients at high risk for recurrent cutaneous or mucosal melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.

Systemic adjuvant therapy for adult patients at high risk for recurrent cutaneous or mucosal melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.

Journal: Current oncology (Toronto, Ont.)

Published: March 29, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026